Skip to content

Clinical trials

Phase 2 Cholestasis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholestasis Phase: Phase 2 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20093
20101
20141
20161
20171
20201
20212
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Unknown status2
Withdrawn1
Recruiting1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mirum Pharmaceuticals, Inc.3
Amarnath, Rathna, M.D.1
Cindy Haller1
Conatus Pharmaceuticals Inc.1
GlaxoSmithKline1
HighTide Therapeutics (Hong Kong) Limited1
LISCure Biosciences1
Mayo Clinic1
National Center for Research Resources (NCRR)1
The University of Texas Health Science Center at San Antonio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholestasis15
Pruritus5
Cholangitis, Sclerosing3
Liver Cirrhosis, Biliary3
Hyperphagia2
Liver Diseases2
Short Bowel Syndrome2
Bile Duct Diseases1
Biliary Tract Diseases1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.